Oncoceutics competitors and similar companiesClear all

Oncoceutics's competitors and similar companies include Jiangsu Hansoh Pharmaceutical Group, PLIVA and Ablynx.
Oncoceutics
Oncoceutics
Oncoceutics is a drug discovery and development company focused on selective G protein-coupled receptor antagonists for oncology.
Jiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group
Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.
PLIVA
PLIVA
PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.
Ablynx
Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
Founding Date
Founding Date
2009
Founding Date
1995
Founding Date
1921
Founding Date
2001
Type
Type
Subsidiary
Type
Public
Type
Subsidiary
Type
Subsidiary
Tags
Locations
Locations
Philadelphia, US HQ
Locations
Lianyungang Shi, CN HQ
Locations
Zagreb, HR HQ
Locations
Gent, BE HQ
Employees
Employees
12
Employees
10,78311% decrease
Employees
1,5401% increase
Employees
2702% decrease
Twitter followers
Twitter followers
313
Twitter followers
N/A
Twitter followers
1 k
Twitter followers
280
Employee Rating
Employee Rating
5
Employee Rating
N/A
Employee Rating
3.7
Employee Rating
3.3

Financial

Revenue (est.)
Revenue (est.)
$5.2m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
€85.2m (FY, 2016)
Net income
Net income
($3.7m) (FY, 2019)
Net income
N/A
Net income
N/A
Net income
(€1.1m) (FY, 2016)
For sources of this data, please see the company profile

View company profiles

Jiangsu Hansoh Pharmaceutical Group
HQ
Lianyungang Shi, CN
Employees
10,783↓ 11% decrease

Jiangsu Hansoh Pharmaceutical Group is a pharmaceutical company.

View company
PLIVA
HQ
Zagreb, HR

PLIVA HRVATSKA is a pharmaceutical company focused on the development of generic and niche products.

View company
Ablynx
HQ
Gent, BE

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.

View company